Non universality of entanglement convertibility

Recently, it has been suggested that operational properties connected to quantum computation can be alternative indicators of quantum phase transitions. In this work we systematically study these operational properties in 1D systems that present phase transitions of different orders. For this purpose, we evaluate the local convertibility between bipartite ground states. Our results suggest that the operational properties, related to non-analyticities of the entanglement spectrum, are good detectors of explicit symmetries of the model, but not necessarily of phase transitions. We also show that thermodynamically equivalent phases, such as Luttinger liquids, may display different convertibility properties depending on the underlying microscopic model.Comment: 5 pages + references, 4 figures - improved versio

Cultivares de arroz de sequeiro para o Território Federal do Amapá.

bitstream/item/57592/1/CPATU-ComTec29.pd

Cultivares de arroz de sequeiro para o Território Federal de Roraima.

bitstream/item/33539/1/CPATU-CirTec18.pd

Physical performance and decision making in association football referees: A naturalistic study.

Although researchers have independently investigated the physical and decision-making (DM) demands experienced by sports officials, the combined impact of locomotion and physiological factors upon DM has received little attention. Using an innovative combination of video and Global Positioning System (GPS) technology this study explored the movement, heart rate (HR) and DM of experienced football referees in their natural performance environment. A panel of independent referees analysed incidents (n = 144) taken from five referees in seven games in the New Zealand Football Championship (2005/06). The match-day referees made accurate decisions on 64% of the incidents, although their accuracy levels were not related to variables such as movement speed, HR, and cumulative distance covered. Interestingly, referees were on average only 51% accurate in the opening fifteen minutes of each half compared to 70% accuracy at all other times. This study demonstrated that it is possible to combine new emerging technologies to conduct a comprehensive study of naturalistic decision-making in sport

Sistema de controle e monitoramento da pesca de Mato Grosso: SISCOMP/MT- pesca amadora.

O Sistema tem como objetivo coletar, analisar e disponibilizar informações sobre a pesca amadora e profissional-artesanal, com a parceria destes setores. Serão obtidas informações tais como, quantidade de pescado capturado por espécie, por rio, por mês, número mensal e rendimento dos pescadores que atuaram nos diferentes rios. Além destas, para a pesca amadora, o SISCOMP/MT fornecerá informações sobre o perfil dos pescadores amadores e suas motivações para visitar a região, características de suas viagens e principais serviços utilizados, que estarão disponíveis para o setor turístico pesqueiro de Mato Grosso.bitstream/CPAP-2009-09/56854/1/FOL117.pd

Controle de ervas daninhas na cultura da pimenta-do-reino na região Transamazônia.

bitstream/item/57733/1/Altamira-PA2-1981.pd

Plantas daninhas consumidas por bovinos em pastagem estabelecida em área de vegetação secundária no nordeste paraense.

Resumos do 24º Congresso Brasileiro da Ciência das Plantas Daninhas, 2004, São Pedro, PS

CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis

Myelofibrosis (MF) is characterized by increased circulating hematopoietic progenitor cells (HPCs), abnormal cytokine levels, and the survival advantage of neoplastic progenitors over their normal counterparts, which leads to progressive disappearance of polyclonal hematopoiesis. CD47 is a surface glycoprotein with many functions, such as acting as a phagocytosis inhibitor of the expressing cell, that is increased in normal hematopoietic stem and progenitor cells mobilized into the blood and several human cancer-initiating cells, such as in acute myeloid leukemia. We compared CD47 expression in hematopoietic stem and progenitor cells of patients with MF and controls and found it to be decreased in progenitors of MF. Exposure of control HPCs to the cytokines transforming growth factor β and stromal-derived factor 1, which are important regulators of hematopoietic stem cell cycling and are overexpressed in patients with MF, did not modulate CD47 expression

Controle integrado de plantas invasoras em pastagens cultivadas no município de Terra Alta, Nordeste paraense.

bitstream/item/48597/1/Boletim-PD-25-AMAZ-ORIENTAL.pd

Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach

Background: TRK fusion cancer results from gene fusions involving NTRK1, NTRK2 or NTRK3. Larotrectinib, the first selective TRK inhibitor, has demonstrated an overall response rate (ORR) of 75% with a favorable safety profile in the first 55 consecutively enrolled adult and pediatric patients with TRK fusion cancer (Drilon et al.,NEJM2018). Here, we report the clinical activity of larotrectinib in an additional 35 TRK fusion cancer patients and provide updated follow-up of the primary analysis set (PAS) of 55 patients as of 19thFeb 2018. Methods: Patients with TRK fusion cancer detected by molecular profiling from 3 larotrectinib clinical trials (NCT02122913, NCT02637687, and NCT02576431) were eligible.Larotrectinib was administered until disease progression, withdrawal, or unacceptable toxicity. Disease status was assessed using RECIST version 1.1. Results: As of Feb 2018, by independent review, 6 PRs in the PAS deepened to CRs. The median duration of response (DoR) and progression-free survival in the PAS had still not been reached, with 12.9 months median follow-up. At 1 year, 69% of responses were ongoing, 58% of patients remained progression-free and 90% of patients were alive. An additional 19 children and 25 adults (age range, 0.1-78 years) with TRK fusion cancer were enrolled after the PAS, and included cancers of the salivary gland, thyroid, lung, colon, melanoma, sarcoma, GIST and congenital mesoblastic nephroma. In 35 evaluable patients, the ORR by investigator assessment was 74% (5 CR, 21 PR, 6 SD, 2 PD, 1 not determined). In these patients, with median follow-up of 5.5 months, median DoR had not yet been reached, and 88% of responses were ongoing at 6 months, consistent with the PAS. Adverse events (AEs) were predominantly grade 1, with dizziness, increased AST/ALT, fatigue, nausea and constipation the most common AEs reported in ≥ 10% of patients. No AE of grade 3 or 4 related to larotrectinib occurred in more than 5% of patients. Conclusions: TRK fusions are detected in a broad range of tumor types. Larotrectinib is an effective age- and tumor-agnostic treatment for TRK fusion cancer with a positive safety profile. Screening patients for NTRK gene fusions in solid- and brain tumors should be actively considered